Method Article

Establishment and Evaluation of a Candida albicans Water-Soluble Extract-Induced Murine Model of Kawasaki Disease-Associated Coronary Arteritis

DOI:

10.3791/69041

⸱

November 7th, 2025

In This Article

Summary

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The CAWS-induced mouse model effectively simulates the progression of Kawasaki disease from acute inflammation to chronic fibrosis, revealing key pathological and immunopathological features, and may facilitate the development of targeted therapeutic strategies for Kawasaki disease.

Abstract

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Kawasaki disease (KD) is a systemic vasculitis primarily affecting children, with coronary artery lesions being its most severe complication. In this study, an optimized mouse KD model was established using the water-soluble extract of Candida albicans (CAWS). Myocardial inflammation and related pathological changes were evaluated using HE staining and Masson trichrome staining. The immunofluorescence technique detected the infiltration of immune cells in cardiac tissue. The expression and localization of VDAC1 protein in myocardial tissue were detected by immunohistochemistry. In vitro, a phagocytic model was established by co-culturing RAW264.7 macrophages with Candida albicans spores, and the formation and function of autophagolysosomes were assessed using LC3 immunofluorescence staining and a Lyso-Tracker Red probe. Through dose screening, it was determined that 8 mg was the optimal modeling dose for inducing coronary artery inflammation, with a moderate mortality rate at this dose. HE staining showed that CAWS injection stably induced coronary artery lesions consistent with the characteristics of human Kawasaki disease in mice. Masson staining confirmed that there was significant collagen fiber deposition around the coronary arteries and aorta in the CAWS group of mice, which closely coincided with the inflammatory area, and a statistically significant difference was observed from the control group at 14 days (p < 0.001). Immunofluorescence revealed that, on the 14th day of modeling, the infiltration of multiple immune cells in the cardiac tissue of the CAWS group had significantly increased (p < 0.001). The immunohistochemical results showed that, on the 28th day of modeling, the expression of VDAC1 protein in the myocardial tissue of the CAWS group was significantly upregulated (p < 0.001). In vitro experiments have shown that in macrophages infected with Candida albicans spores, the formation of autophagolysosomes increases in the early stage, while autophagic flow is blocked in the later stage, suggesting a functional disorder.

Introduction

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Kawasaki disease (KD), a form of mucocutaneous lymph node syndrome, is an autoimmune disease that occurs in children under 5 years old and is accompanied by febrile vasculitis1,2,3. Studies indicate that untreated or treatment courses exceeding 10 days of severe KD are prone to induce serious cardiovascular complications, mainly including coronary aneurysms and coronary artery stenosis4,5. The rupture of coronary aneurysms may lead to cardiogenic shock or even sudden death, which is the main cause of acquired heart di....

Access restricted. Please log in or start a trial to view this content.

Protocol

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

All research experiments involving animal data were approved by the ethics committee of the Affiliated Huai'an No.1 People's Hospital of Nanjing Medical University (KY-2024-250-01). The reagents and the equipment used are listed in the Table of Materials.

1. Preparation of CAWS

  1. Inoculate Candida albicans in Sabouraud dextrose broth according to the established protocol by Duong et al.18. Then, culture the inoculated broth anaerobically at 37 °C for 48 h in a sealed anaerobic chamber with a gas mixture.
    ​NOTE: To ensure the sterility of the culture medium....

Access restricted. Please log in or start a trial to view this content.

Results

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Initially, we systematically evaluated the myocardial pathological changes induced by different doses of CAWS in mice. No deaths were observed in the PBS control group, the 4 mg CAWS group, and the 8 mg CAWS group (n=20 in each group). In contrast, the inflammatory response in the 4 mg group was mild and did not meet the modeling requirements. The mortality rate was higher in the 12 mg CAWS group (9/20, 45%), and deaths occurred from the 3rd to the 10th day after injection. These findings.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Coronary artery aneurysms (CAA) and myocardial fibrosis in KD are the main causes of long-term cardiovascular events. Despite the progress made in acute phase treatment, approximately 5% of patients still develop persistent CAA28,29. The mechanism of this delayed pathological change is still unclear, and there is an urgent need for animal models to reveal its dynamic process30. Due to the extremely limited cardiac tissue samples of human K.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The authors have nothing to disclose.

Acknowledgements

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Thank you to the team members for their support and contribution to this experiment. The research was supported by the following projects: General project of the Development Fund of Xuzhou Medical University Affiliated Hospital (XYFM202234) and Natural Science Specialized Soft Project on the Life and Health of Huai'an City (2023KX0006).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
a goat secondary antibody to Rabbit IgG Alexa Fluor 488abcamab15081a goat secondary antibody to Rabbit IgG Alexa Fluor 488
Anaerobic chamberThermo ScientificThermo ScientificAnaerobic chamber
Aniline blueSolarbioG3668Aniline blue
anti-LC3abcamab192890the primary antibody against LC3
Biological safety cabinetThermo Scientific1500Biological safety cabinet
BSASolarbioA8020BSA
Candida albicans (strain)NBRC1385Candida albicans (strain)
CD3eBD Bioscience561827FITC Hamster Anti-Mouse CD3e(145-2C11)
CD86BD Bioscience105013CD86
CD8aBD Bioscience100713CD8a
Cell culture incubatorThermo Scientific311Cell culture incubator
CentrifugeThermo ScientificST4R PlusCentrifuge
Confocal microscopeOlympusIX73Confocal microscope
DAPIBeyotime Biotechnology P0131-25mlDAPI
DMEMGibco11965126DMEM
Embedding machineP.S.J MEDICALBM450AEmbedding machine
EosinSolarbio G1100Eosin
F4/80BD Bioscience123109F4/80
FBSGibco16000044FBS
FormaldehydeSolarbio P1110Formaldehyde
Fully automatic tissue dehydratorLeica BiosystemsASP3005Fully automatic tissue dehydrator
Glass microscope slidesCitotest250124A1Glass microscope slides
H&E dyeBeyotime Biotechnology C0105MH&E dye
IHC KitAbsin Biotechnologyabs996-5mlIHC Kit
LC3 probeBeyotime Biotechnology C3018MLC3 probe
Low Profile Microtome BladesThermo Fisher3052835Low Profile Microtome Blades
lysosome probeBeyotime Biotechnology C1046lysosome probe
Marker penDeliSK109Marker pen
Masson dyeBeyotime Biotechnology C0189MMasson dye
MicrotomeLeica BiosystemsHistoCore BIOCUTMicrotome
Neutral gumSolarbi G8590Neutral gum
NK1.1BD Bioscience561117NK1.1
Optical microscopeNikonNikonOptical microscope
ParaffinSolarbio YA0012Paraffin
Paraffin waxSolarbioYA0012Paraffin wax
PBSSolarbioP1020PBS
Phosphomolybdic acidSolarbioG3472Phosphomolybdic acid
VDAC1Abcamab34726Anti-VDAC1

References

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,
  1. Jone, P. -N., et al. Update on diagnosis and management of Kawasaki disease: A scientific statement from the American Heart Association. Circulation. 150 (23), e481-e500 (2024).
  2. Goel, A. R., Yalcindag, A. An update on Kawasaki disease. Curr Rheumatol....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

Kawasaki DiseaseCoronary ArteritisCandida Albicans ExtractMurine ModelCoronary Artery LesionsMyocardial InflammationHE StainingMasson Trichrome StainingImmunofluorescence StainingVDAC1 Expression

Related Articles